Twist Bioscience Corporation (TWST) financial statements (2020 and earlier)

Company profile

Business Address 681 GATEWAY BLVD.
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End September 30
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
TTM
9/30/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments103138
Cash and cash equivalents2647
Short-term investments7791
Restricted cash and investments 0
Receivables1312
Inventory, net of allowances, customer advances and progress billings77
Inventory77
Other undisclosed current assets63
Total current assets:129160
Noncurrent Assets
Operating lease, right-of-use asset37 
Property, plant and equipment2121
Intangible assets, net (including goodwill)22
Goodwill11
Intangible assets, net (excluding goodwill)01
Restricted cash and investments11
Other noncurrent assets24
Total noncurrent assets:6327
TOTAL ASSETS:192187
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2326
Accounts payable910
Accrued liabilities56
Employee-related liabilities910
Debt123
Estimated litigation liability23 
Other liabilities11
Total current liabilities:5830
Noncurrent Liabilities
Long-term debt and lease obligation314
Long-term debt, excluding current maturities44
Operating lease, liability28 
Liabilities, other than long-term debt00
Other liabilities00
Total noncurrent liabilities:315
Total liabilities:8935
Stockholders' equity
Stockholders' equity attributable to parent103152
Additional paid in capital477470
Accumulated other comprehensive income00
Accumulated deficit(374)(319)
Total stockholders' equity:103152
TOTAL LIABILITIES AND EQUITY:192187

Income statement (P&L) ($ in millions)

12/31/2019
TTM
9/30/2019
Revenues6054
Cost of revenue(49)(47)
Gross profit:117
Operating expenses(152)(116)
Operating loss:(142)(109)
Nonoperating income33
Investment income, nonoperating33
Interest and debt expense(1)(1)
Loss from continuing operations before income taxes:(140)(107)
Income tax expense(0)(0)
Net loss available to common stockholders, diluted:(141)(108)

Comprehensive Income ($ in millions)

12/31/2019
TTM
9/30/2019
Net loss:(141)(108)
Other comprehensive income00
Comprehensive loss, net of tax, attributable to parent:(141)(108)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: